Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Isradipine for Bipolar Depression
NCT01784666Phase 2Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Isradipine in bipolar disorder (BD), sponsored by Massachusetts General Hospital. Started Feb 2013; status: terminated.
02
Drugs
Isradipine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01784666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784666.